IL‐10 (Figure 8), IFN‐γ (Figure 9), and MCP‐1 (Figure 10) are also increased, even though no difference was observed between COVID‐19 and COVID‐19 AKI groups in what concerns INF‐gamma. The gene discussed is CCL2; the disease is acute kidney injury.